about
Thalidomide-induced teratogenesis: history and mechanismsEpidemiological surveillance of birth defects compatible with thalidomide embryopathy in BrazilDegenerative Changes in the Cervical Spine Are More Common in Middle-Aged Individuals with Thalidomide Embryopathy than in Healthy ControlsTeratogens: a public health issue - a Brazilian overviewTeratogen update: thalidomide: a review, with a focus on ocular findings and new potential uses.Immunomodulation by thalidomide and thalidomide analoguesThalidomide: the tragedy of birth defects and the effective treatment of disease.Teratogenic effects of thalidomide: molecular mechanisms.Long-term follow-up of thalidomide embryopathy: malformations and development of osteoarthritis in the lower extremities and evaluation of upper extremity function.Phocomelia: a worldwide descriptive epidemiologic study in a large series of cases from the International Clearinghouse for Birth Defects Surveillance and Research, and overview of the literatureIn vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems.Shared mechanism of teratogenicity of anti-angiogenic drugs identified in the chicken embryo model.Multicenter investigation of lifestyle-related diseases and visceral disorders in thalidomide embryopathy at around 50 years of age.Deciphering the mystery of thalidomide teratogenicity.Thalidomide dose proportionality assessment following single doses to healthy subjects.Late-onset neurological symptoms in thalidomide-exposed subjects: a study of an Australasian cohort.Clinical use and control of the dispensing of thalidomide in Brasilia-Federal District, Brazil, from 2001 to 2012.Thalidomide, semen distribution, teratogenicity... and cost.The epidemiology of developmental disabilities in low-income countries.Assessment of the in vitro and in vivo genotoxicity of Thalomid (thalidomide).Thalidomide embryopathy: Follow-up of cases born between 1959 and 2010.The return of thalidomide: are birth defects surveillance systems ready?ECLAMC: the Latin-American collaborative study of congenital malformations.[Thalidomide in Brazil: monitoring with shared responsibility?].Thalidomide Embryopathy: An Enigmatic ChallengeBig risks in small groups: The difference between epidemiology and counselling
P2860
Q28085087-A17FA4C5-8655-4E2C-BAB1-BE57DDD25099Q28478928-1EA413EE-2AE4-426A-89DC-8DAC2B34C5E8Q28552048-5E68A46D-05D8-449D-A6A5-64CB63D6CEE7Q30145580-19B8F764-F0A3-47CD-A9F4-3B5CD4C02130Q33753486-76501160-5C47-494C-936A-80360685E372Q33782386-01078906-86DD-4C8F-AEDF-B97A0D0F3B19Q34179690-DE5321A5-E5F9-45D8-92F3-A54ABC6CF4D6Q34660391-C89A10B0-D818-4D78-A8EA-873EE487B4FEQ35336255-4B71CB71-AF60-4635-8DB9-FEC1F88D2D1DQ35592267-F0A95F77-6EC8-4045-A20D-716DD32A3705Q36001001-A98FB3E8-CC99-4756-A898-AED391734904Q37117375-A2CFC1FB-DB37-49A7-97B3-95EDC728C9EFQ37505457-5935ECB8-0622-49CC-A2B2-64C8F9F3EBFCQ37986238-749DBCE7-44BB-4C0A-B6FF-A6AE3B61AFF7Q43637283-F468D731-B454-491F-9617-DF4727CD7E9BQ44048966-A87E1351-D746-46BD-A4B0-F16A466232EEQ44217113-7B9DE61B-B8BB-43BE-B67A-6258AF4D735EQ46918579-EB05A73F-2FA2-415A-AC7E-42DD5EBA0D64Q47612018-0040FAB3-3A93-48C7-AA7F-450C9F1804C6Q50119468-5FBFA42A-F629-4F10-81CD-F961BE76586EQ50908946-06F068C2-B812-4B3F-899D-A8665F65BB2DQ52191299-7728BAC8-4031-4E4A-8A15-108D9E70A09CQ53282251-4DE977F8-FCBA-442C-93FC-9B5D30737231Q55032965-0C56678C-33BC-401C-92CF-8EDB30F16EF1Q57129133-FBA37A4C-065F-4363-8F61-953A9F6F216CQ57386663-1657EA59-A61C-4274-BF4F-BD31F9A0A2BC
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Thalidomide, a current teratogen in South America.
@ast
Thalidomide, a current teratogen in South America.
@en
Thalidomide, a current teratogen in South America.
@nl
type
label
Thalidomide, a current teratogen in South America.
@ast
Thalidomide, a current teratogen in South America.
@en
Thalidomide, a current teratogen in South America.
@nl
prefLabel
Thalidomide, a current teratogen in South America.
@ast
Thalidomide, a current teratogen in South America.
@en
Thalidomide, a current teratogen in South America.
@nl
P2093
P2860
P1476
Thalidomide, a current teratogen in South America.
@en
P2093
Ashton-Prolla P
Barreda-Mejia E
Castilla EE
Cavalcanti DP
Correa-Neto J
Delgadillo JL
P2860
P304
P356
10.1002/(SICI)1096-9926(199612)54:6<273::AID-TERA1>3.0.CO;2-#
P577
1996-12-01T00:00:00Z